Trimi is a 100% online telehealth platform prescribing compounded semaglutide and tirzepatide — the same active ingredients as Wegovy and Mounjaro — through US-licensed clinicians, shipped free overnight with no pharmacy trips.
Its standout is price: semaglutide from $99/month and tirzepatide from $125/month, flat at every dose so you never pay more as treatment is adjusted. One membership covers medication, clinician visits, ongoing check-ins and shipping, and it is FSA/HSA eligible.
Clinical oversight is led by a licensed medical director across all 50 states, medication is compounded by state-licensed 503A pharmacies, and the platform is LegitScript-certified. As with all compounded programs, the formulations are not FDA-approved.
Pros
- Compounded semaglutide from $99/mo, tirzepatide from $125/mo
- Flat pricing at every dose — no increases as you titrate
- Free overnight shipping, FSA/HSA eligible, LegitScript-certified
Cons
- Compounded only — no brand-name meds
- Compounded medications are not FDA-approved
| Starting price | $99/mo |
|---|---|
| Current offer | Semaglutide from $99/mo · flat pricing |
| Medications | Semaglutide, Tirzepatide, Compounded GLP-1 |
| Shipping time | Overnight (free) |
| Insurance | No — but FSA/HSA eligible |
| Best for | People who want the most affordable flat-priced GLP-1 |